ASUS Announces Advanced AI POD Design Built with NVIDIA at Computex 2025
Enterprise-optimized reference architectures for accelerated AI infrastructure solutions
TAIPEI, May 19, 2025 /CNW/ -- ASUS today announced at Computex 2025 that it is pioneering the next wave of intelligent infrastructure with the launch of the NVIDIA ® Enterprise AI Factory validated design, featuring advanced ASUS AI POD designs with optimized reference architectures. These solutions are available as NVIDIA-Certified Systems across NVIDIA Grace Blackwell, HGX, and MGX platforms, supporting both air-cooled and liquid-cooled data centers. Engineered to accelerate agentic AI adoption at every scale, these innovations deliver unmatched scalability, performance, and thermal efficiency, making them the ultimate choice for enterprises seeking to deploy AI at unprecedented speed and scale.
NVIDIA Enterprise AI Factory with ASUS AI POD
The validated NVIDIA Enterprise AI Factory with ASUS AI POD design provides guidance for developing, deploying, and managing agentic AI, physical AI, and HPC workloads on the NVIDIA Blackwell platform on-premises. Designed for enterprise IT, it provides accelerated computing, networking, storage, and software to help deliver faster time-to-value AI factory deployments while mitigating deployment risks.
Below are the reference architecture designs that help clients use approved practices, acting as a knowledge repository and a standardized framework for diverse applications.
For massive-scale computing, the advanced ASUS AI POD, accelerated by NVIDIA GB200/GB300 NVL72 racks and incorporating NVIDIA Quantum InfiniBand or NVIDIA Spectrum -X Ethernet networking platforms, features liquid cooling to enable a non-blocking 576-GPU cluster across eight racks, or an air-cooled solution to support one rack with 72 GPUs. This ultra-dense, ultra-efficient architecture redefines AI reasoning computing performance and efficiency.
AI-ready racks: Scalable power for LLMs and immersive workloads
ASUS presents NVIDIA MGX-compliant rack designs with ESC8000 series featuring dual Intel ® Xeon ® 6 processors and RTX PRO ™ 6000 Blackwell Server Edition with the latest NVIDIA ConnectX-8 SuperNIC – supporting speeds of up to 800Gb/s or other scalable configurations — delivering exceptional expandability and performance for state-of-the-art AI workloads. Integration with the NVIDIA AI Enterprise software platform provides highly-scalable, full-stack server solutions that meet the demanding requirements of modern computing.
In addition, NVIDIA HGX reference architecture optimized by ASUS delivers unmatched efficiency, thermal management, and GPU density for accelerated AI fine-tuning, LLM inference, and training. Built on the ASUS XA NB3I-E12 with NVIDIA HGX B300 or ESC NB8-E11 embedded with NVIDIA HGX B200, this centralized rack solution offers unmatched manufacturing capacity for liquid-cooled or air-cooled rack systems, ensuring timely delivery, reduced total cost of ownership (TCO), and consistent performance.
Engineered for the AI Factory, enabling next-gen agentic AI
Integrated with NVIDIA's agentic AI showcase, ASUS infrastructure supports autonomous decision-making AI, featuring real-time learning, and scalable AI agents for business applications across industries.
As a global leader in AI infrastructure solutions, ASUS provides complete data center excellence with both air- and liquid-cooled options — delivering unmatched performance, efficiency, and reliability. We also deliver ultra-high-speed networking, cabling and storage rack architecture designs with NVIDIA-certified storage, RS501A-E12-RS12U as well as the VS320D series to ensure seamless scalability for AI/HPC applications. Additionally, advanced SLURM-based workload scheduling and NVIDIA UFM fabric management for NVIDIA Quantum InfiniBand networks optimize resource utilization, while the WEKA Parallel File System and ASUS ProGuard SAN Storage provide high-speed, scalable data handling.
ASUS also provides a comprehensive software platform and services, including ASUS Control Center (Data Center Edition) and ASUS Infrastructure Deployment Center (AIDC), ensuring seamless development, orchestration, and deployment of AI models. ASUS L11/L12-validated solutions empower enterprises to deploy AI at scale with confidence through world-class deployment and support. From design to deployment, ASUS is the trusted partner for next-generation AI Factory innovation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
44 minutes ago
- Cision Canada
Perimeter Announces Closing of Prospectus Offering
TORONTO and DALLAS, June 3, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (" Perimeter" or the " Company"), a commercial-stage medical technology company, is pleased to announce that it has completed its previously announced prospectus offering (the " Offering") of units of the Company (the " Units") and pre-funded units of the Company. The Offering was completed on a reasonable "best efforts" agency basis pursuant to an agency agreement (the " Agency Agreement") dated May 29, 2025 between the Company and A.G.P. Canada Investments ULC (the " Agent"). Pursuant to the Offering, the Company has issued an aggregate of 10,432,801 Units at a price of $0.30 per Unit (the " Offering Price") for aggregate gross proceeds of $3,129,840. Each Unit is comprised of one common share in the capital of the Company (each a " Common Share") and one Common Share purchase warrant (each a " Warrant"). Each Warrant entitles the holder to acquire an additional Common Share for a period of 60 months, at an exercise price of $0.35. Pursuant to the terms of the Agency Agreement, the Agent was entitled to receive a cash fee equal to 7.0% of the gross proceeds raised under the Offering, and compensation options equal to 5.0% of the aggregate number of Units issued under the Offering (the " Compensation Options"), with a reduced cash commission of 3.5% and Compensation Options equal to 2.5% payable in respect of Units sold to certain purchasers on a president's list. In addition, the Agent will receive no cash commission or Compensation Options with respect to sales to certain insiders of the Company. Each Compensation Option entitles the Agent to buy one Common Share at the same price as the price per Unit under the Offering. The Compensation Options are exercisable until that date which is 36 months following the closing date. The Company intends to use the net proceeds from the Offering to continue the commercialization of its technology, establish clinical evidence and continue product development. The Company also intends to use the net proceeds for working capital and other general corporate purposes. The Company may close additional tranches of the Offering for total gross proceeds of up to $15,000,000 (inclusive of the initial closing). The Offering was completed by way of a short form prospectus dated May 29, 2025 (the " Prospectus"). The Prospectus and the Agency Agreement are available on SEDAR+ at and contain important detailed information about the Offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the " 1933 Act") and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements of the 1933 Act, and applicable state securities laws. Social Capital, a control person of the Company purchased a total of 115,217 Units under the Offering. The placement to such person constituted a "related party transaction" within the meaning of TSX Venture Exchange Policy 5.9 and Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (" MI 61-101"). The Company has relied on exemptions from the formal valuation and minority shareholder approval requirements of MI 61- 101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of related party participation in the placement as neither the fair market value (as determined under MI 61-101) of the subject matter of, nor the fair market value of the consideration for, the transaction, insofar as it involved the related parties, exceeded 25% of the Company's market capitalization (as determined under MI 61-101). The Company has not filed a material change report more than 21 days before the expected closing of the Offering as the details of the Offering and the participants thereof were only finalized shortly before the closing of the Offering. About Perimeter Medical Imaging AI, Inc. Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The Company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month. Perimeter B-Series OCT is limited by U.S. law to investigational use and not available for sale in the United States. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. For more information, please visit Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, statements regarding the use of proceeds from the Offering and the closing of additional tranches, are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Annual Information Form for the year ended December 31, 2024, which is available on Perimeter's SEDAR+ profile at and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws. Contacts Stephen Kilmer Investor Relations Direct: 647-872-4849 Email: [email protected] Adrian Mendes Chief Executive Officer Toll-free: 888-988-7465 (PINK) Email: [email protected]
Cision Canada
an hour ago
- Cision Canada
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information
NASDAQ| TSX: ACB EDMONTON, AB, June 3, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2025 on Wednesday, June 18, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter fiscal year 2025 before the opening of markets that same day. Conference Call Details Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at under "Events". About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at and follow us on X and LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Forward Looking Statements This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the timing of the release of the Company's financial statements for fourth quarter and fiscal year ended March 31, 2025 and scheduling of the conference call to discuss results. These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the timing, magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 20, 2024 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at and filed with and available on the SEC's website at The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
Globe and Mail
an hour ago
- Globe and Mail
This Former Penny Stock is Now Outperforming Even Nvidia Stock After 4,658% Growth
If you were given a chance to guess the best-performing stock of the past 5 years, many would guess Nvidia (NVDA), Amazon (AMZN), Apple (AAPL), or some other AI-adjacent company. In reality, you wouldn't even be close. During the lows of the COVID-19 stock market crash, the stock in question reached a low of $1.02 but has since rocketed to $48.54 in today's price, a gain of 4,658%. Over the past five years, Build-A-Bear Workshop (BBW), a specialty retailer known for its interactive stuffed animal experiences, has delivered a remarkable performance on Wall Street — outpacing not only the S&P 500 Index (SPY) but, in a surprising twist, even tech giant Nvidia in terms of stock price appreciation. Following the initial sell-off from the pandemic, Build-A-Bear began to recover. Shortly after bouncing off the $1 line, the stock doubled from its lows in only about a month. This means that over the past five years from today's date, Build-A-Bear is up 1,733%. Nvidia is up only 1,490% in that same time period. Extraordinary Stock Gains Build-A-Bear Workshop's stock has soared from under $3 in mid-2020 to over $50 at its peak in June 2025, representing over a tenfold increase. This explosive growth far exceeds the gains of many high-profile technology stocks, including Nvidia, whose own meteoric rise has been a central story of the artificial intelligence (AI) boom. BBW's 74% growth in the past year alone has trounced broader market indices and many individual tech leaders. BBW's financials underpin its stock's rally. In the first quarter of 2025, the company reported record results, with an 11.9% increase in total revenues and a 42.7% year-over-year jump in earnings per share (EPS). The company's revenue for the trailing twelve months reached $496 million, with consistent year-over-year growth since 2021. This momentum is attributed to: Aggressive expansion of its Mini Beans collectible line and new store openings International growth and strategic partnerships A robust omnichannel retail strategy, blending in-store experiences with digital transformation BBW's profitability metrics are strong, with a market capitalization now exceeding $640 million, a price/earnings (P/E) ratio below 12, and healthy cash flow. Analysts continue to rate the stock as a 'Buy,' with price targets as high as $60 and no 'Sell' recommendations in sight. Comparison to Nvidia While Nvidia remains a dominant force in the semiconductor and AI sectors, its stock, despite significant gains, has not matched the percentage increase seen in Build-A-Bear Workshop over the same period. Nvidia's growth, though impressive in absolute terms, is outpaced by BBW's relative surge from a low base, highlighting the potential for outsized returns in overlooked sectors. BBW's transformation from a mall-based novelty retailer to a dynamic, omnichannel brand has been key. The company's focus on experiential retail, product innovation, and international partnerships has resonated with consumers and investors alike. Its ability to consistently beat earnings expectations and deliver shareholder returns through dividends and buybacks has further fueled its ascent. Build-A-Bear Workshop's five-year run is a case study in how nimble strategy and brand reinvention can deliver outsized returns, even eclipsing tech titans like Nvidia in relative stock performance. As of mid-2025, BBW stands as one of the market's most unexpected success stories, proving that sometimes, the bear can outrun the bull.
